A man has revealed he has been injected with the Ebola virus ON PURPOSE in a bid to fight the deadly disease.
Peter Hubbard said he hopes the small risk he is taking could help create a vaccine to prevent further outbreaks of the disease, which has claimed thousands of lives in west Africa.
Mr Hubbard, 35, is one of 20 people taking part in clinical trials for a vaccine at the National Institutes of Health (NIH) in the United States.
The vaccine he is trialling, co developed by GlaxoSmithKline and the NIH, consists of a common cold virus, called an adenovirus, that has been engineered to carry TWO genes of the Ebola virus.
No comments:
Post a Comment